Treatment options in Invasive Aspergillosis
- PMID: 25328449
- PMCID: PMC4200583
- DOI: 10.1007/s40506-014-0016-2
Treatment options in Invasive Aspergillosis
Keywords: antifungals; immunotherapy; invasive aspergillosis; neutropenia.
Figures
References
-
- De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–1821. - PMC - PubMed
-
- Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47:674–683. - PMC - PubMed
-
- Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–360. - PubMed
-
- Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091–1100. - PubMed
-
- Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin Infect Dis. 2010;50:1101–1111. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources